Home About GBNEU Projects

Search form

About GBN

EU Projects

The German Biobank Node (GBN) is currently involved in two EU-funded projects: EvolveBBMRI, coordinated by BBMRI-ERIC, and RESOLVE, coordinated by Martin Luther University Halle-Wittenberg.

EvolveBBMRI

 

The "EvolveBBMRI" project (Accelerating Datafication for Support of EU Health Priorities, Greening of Biobanks and Integrated Approach to "One Health"), which is coordinated by the European biobank network BBMRI-ERIC (Biobanking and BioMolecular Resources Research Infrastructure - European Research Infrastructure Consortium) in cooperation with ten member states, was officially launched on 30 January 2024 with a kick-off event in Vienna. The aim of the project is to further develop BBMRI-ERIC in the interests of its scientific communities and users, to sharpen its focus on political priorities at EU level and to intensify cooperation with industry.   

EvolveBBMRI comprises four thematic pillars:

  1. Faster "datafication" of biobanks and biomolecular resources to enable reproducible cutting-edge medical research in line with EU health policy priorities
  2. Collaboration with industry for greener biobanks
  3. Measures for the long-term sustainability of BBMRI, taking into account gaps in the research infrastructure landscape
  4. Strengthening career pathways, training and outreach

The German Biobank Node (GBN) is involved in several work packages of the project. In the work package "Acceleration of datafication of biobanks and biomolecular resources to enable reproducible advanced medical research" GBN takes the lead and in the area "Strengthened approach to training and outreach activities to maximise impact" GBN is responsible for several central tasks.  

"EvolveBBMRI" has a duration of three years and a funding volume of around four million euros. GBN will receive 645,000 €.

RESOLVE

The "RESOLVE" project (Residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across Europe) is being carried out by Martin Luther University Halle-Wittenberg in cooperation with 21 institutions from eight European countries and started on 1 April 2024. The aim is to establish a "gold standard" in the treatment of acute myeloid leukaemia (AML) and chronic lymphocytic leukaemia (CLL).   

AML and CLL are among the most common forms of blood cancer in adults. Depending on the stage of the disease, patients receive chemotherapy, immunotherapy or a stem cell transplant. The so-called measurable residual disease (MRD) can be used early on in the course of treatment to determine whether the leukaemia is responding very well to the therapy. It is present when very sensitive measurement methods such as flow cytometry still detect leukaemia cells in the body that cannot be detected with a light microscope. Although MRD has a high predictive value for further treatment, it has not yet been sufficiently scientifically tested to serve as a binding guideline for an individual treatment recommendation. This is now to be clarified by the RESOLVE research network in collaboration with existing expert networks and partnerships with patient involvement. The German Biobank Node (GBN) is involved in the project in an advisory capacity and is contributing its experience in the development of an IT platform.

RESOLVE is part of the "EU Mission on Cancer" funding line, has a duration of five years and a funding volume of eight million euros. GBN receives 50,000 € of this.

Europe Biobank Week 2025

Europe Biobank Week
13.-16. Mai 2025
Bolgna, Italien

Die Europe Biobank Week findet in diesem Jahr vom 13. bis 16. Mai in Bologna, Italien (Bologna Congressi) statt. Die Veranstaltung wird von den europäischen Organisationen BBMRI-ERIC und ESBB gemeinsam ausgerichtet. Auf der Konferenz-Website finden Sie Informationen u. a. zu:

Vertreter*innen aus der Community des German Biobank Node (GBN) und der German Biobank Alliance (GBA) sind mit zahlreichen Beiträgen vertreten:

Dienstag, 13. Mai 2025 

  • 13:00-15:00 Uhr und 15:30-17:30 Uhr: Workshop 4: Basic Auditor Training in line with BBMRI-ERIC Audit Programme, Organisatoren/Referenten: PD Dr. Karoline I. Gaede (BioMaterialBank Nord), Nhutuyen Nguyen (GBN), Stella Antoniou, Nadja Palko, Agnieszka Matera-Witkiewicz, Monica Forni, Andrea Wutte, Rosanna Cardani, Elisa Cantarelli
  • 15:30-17:30 Uhr, Workshop 2b: Enhancing strategic visibility of biobank resources: an interactive workshop on BBMRI-ERIC tools, Organisatoren/Referenten: Zohaib Hassan (GBN), Zdenka Dudova, Kurt Majcen, Katerina Novakova​

Mittwoch, 14. Mai 2025

  • 14:00-15:30 Uhr, Session 3D: Empowering the next generation: Education and training in biobanking, Chairs – PD Dr. Sara Nußbeck, National Node Director des GBN, mit Karine Sargsyan, ESBB
  • 17:30-19:00 Uhr, Session 4A: Clinical biobanks: Bridging research and patient care, SoA Speaker: Dr. Tilman Pfeffer (BioMaterialBank Heidelberg) – Infectious diseases tissue biobanking and biodata management of the German Center for Infection Research – a key infrastructure for multiple research approaches
  • 17:30-19:00 Uhr, Session 4C: Implementing and securing quality control in biobanking, SoA Speaker: Dr. Ronny Baber (Leipzig Medical Biobank) - Enhancing biobanking quality: Validation and verification strategies with insights from the Leipzig Medical Biobank; Sven Heiling (Integrierte Biobank Jena)  – Three years of proficiency testing in liquid biobanking: A proven tool for identifying variations in process and sample quality; PD Dr. Jörg Geiger, (interdisziplinäre Biomaterial- und Datenbank Würzburg) – Monitoring of the cold-chain of deep-frozen samples
  • 17:30-19:00 Uhr, Session 4D: Balancing ethics and innovation: ELSI in biobanking, PD Dr. Jörg Geiger (interdisziplinäre Biomaterial- und Datenbank Würzburg)  – Electronic Consent – the key to compliant, secure and efficient biobanking

Donnerstag, 15. Mai 2025

  • 14:00-15:30 Uhr, Session 7B: Data flows in healthcare integrated biobanking, Chairs – Dr. Daniel Brucker, interdisziplinäre Biomaterial- und Datenbank Frankfurt und ESBB, mit Zdenka Dudova, BBMRI.cz
  • 14:00-15:30 Uhr, Session 7B: Data flows in healthcare integrated biobanking, Dr. Michael Neumann (interdisziplinäre Biomaterial- und Datenbank Würzburg) – Electronic Order Entry and Biobank Registration for Tissue Samples
  • 17:00 -18:00 Uhr: Session 8A: The transformative role of biobanks in public health, Dr. Katharina Hofmann (BioMaterialBank Heidelberg) - The Tumor Tissue Bank of the German National Cohort (NAKO): Pilot of a centralized epidemiologically networked biobanking
  • 17:00-18:00 Uhr, Session 8D: Connecting forces: Effective stakeholder management, Verena Huth (GBN) – Fostering Biobank Sustainability and Patient Participation through Collaborative Advocacy

Freitag, 16. Mai 2025

  • 09:00-10:30 Uhr, Session 7C: Innovative quality concepts, SoA Speaker: Nhutuyen Nguyen (GBN) - Collaborative initiative to a European quality manual for biobanks
  • 12:00-13:30 Uhr, Session 10C: Samples read for multi-omics research, Chairs –  Dr. Ronny Baber, Leipzig Medical Biobank und ESBB, mit Radka Kaneva, BBMRI.bg

Auch in den Poster-Sessions werden GBN-/GBA-Vertreter*innen Arbeitsergebnisse präsentieren: Am 14. Mai, 16-17 Uhr in der ersten Poster-Session und am 16. Mai (gleiche Zeit) in der zweiten.

 

Europe Biobank Week 2025

Europe Biobank Week
13.-16. Mai 2025
Bolgna, Italien

Die Europe Biobank Week findet in diesem Jahr vom 13. bis 16. Mai in Bologna, Italien (Bologna Congressi) statt. Die Veranstaltung wird von den europäischen Organisationen BBMRI-ERIC und ESBB gemeinsam ausgerichtet. Auf der Konferenz-Website finden Sie Informationen u. a. zu:

Vertreter*innen aus der Community des German Biobank Node (GBN) und der German Biobank Alliance (GBA) sind mit zahlreichen Beiträgen vertreten:

Dienstag, 13. Mai 2025 

  • 13:00-15:00 Uhr und 15:30-17:30 Uhr: Workshop 4: Basic Auditor Training in line with BBMRI-ERIC Audit Programme, Organisatoren/Referenten: PD Dr. Karoline I. Gaede (BioMaterialBank Nord), Nhutuyen Nguyen (GBN), Stella Antoniou, Nadja Palko, Agnieszka Matera-Witkiewicz, Monica Forni, Andrea Wutte, Rosanna Cardani, Elisa Cantarelli
  • 15:30-17:30 Uhr, Workshop 2b: Enhancing strategic visibility of biobank resources: an interactive workshop on BBMRI-ERIC tools, Organisatoren/Referenten: Zohaib Hassan (GBN), Zdenka Dudova, Kurt Majcen, Katerina Novakova​

Mittwoch, 14. Mai 2025

  • 14:00-15:30 Uhr, Session 3D: Empowering the next generation: Education and training in biobanking, Chairs – PD Dr. Sara Nußbeck, National Node Director des GBN, mit Karine Sargsyan, ESBB
  • 17:30-19:00 Uhr, Session 4A: Clinical biobanks: Bridging research and patient care, SoA Speaker: Dr. Tilman Pfeffer (BioMaterialBank Heidelberg) – Infectious diseases tissue biobanking and biodata management of the German Center for Infection Research – a key infrastructure for multiple research approaches
  • 17:30-19:00 Uhr, Session 4C: Implementing and securing quality control in biobanking, SoA Speaker: Dr. Ronny Baber (Leipzig Medical Biobank) - Enhancing biobanking quality: Validation and verification strategies with insights from the Leipzig Medical Biobank; Sven Heiling (Integrierte Biobank Jena)  – Three years of proficiency testing in liquid biobanking: A proven tool for identifying variations in process and sample quality; PD Dr. Jörg Geiger, (interdisziplinäre Biomaterial- und Datenbank Würzburg) – Monitoring of the cold-chain of deep-frozen samples
  • 17:30-19:00 Uhr, Session 4D: Balancing ethics and innovation: ELSI in biobanking, PD Dr. Jörg Geiger (interdisziplinäre Biomaterial- und Datenbank Würzburg)  – Electronic Consent – the key to compliant, secure and efficient biobanking

Donnerstag, 15. Mai 2025

  • 14:00-15:30 Uhr, Session 7B: Data flows in healthcare integrated biobanking, Chairs – Dr. Daniel Brucker, interdisziplinäre Biomaterial- und Datenbank Frankfurt und ESBB, mit Zdenka Dudova, BBMRI.cz
  • 14:00-15:30 Uhr, Session 7B: Data flows in healthcare integrated biobanking, Dr. Michael Neumann (interdisziplinäre Biomaterial- und Datenbank Würzburg) – Electronic Order Entry and Biobank Registration for Tissue Samples
  • 17:00 -18:00 Uhr: Session 8A: The transformative role of biobanks in public health, Dr. Katharina Hofmann (BioMaterialBank Heidelberg) - The Tumor Tissue Bank of the German National Cohort (NAKO): Pilot of a centralized epidemiologically networked biobanking
  • 17:00-18:00 Uhr, Session 8D: Connecting forces: Effective stakeholder management, Verena Huth (GBN) – Fostering Biobank Sustainability and Patient Participation through Collaborative Advocacy

Freitag, 16. Mai 2025

  • 09:00-10:30 Uhr, Session 7C: Innovative quality concepts, SoA Speaker: Nhutuyen Nguyen (GBN) - Collaborative initiative to a European quality manual for biobanks
  • 12:00-13:30 Uhr, Session 10C: Samples read for multi-omics research, Chairs –  Dr. Ronny Baber, Leipzig Medical Biobank und ESBB, mit Radka Kaneva, BBMRI.bg

Auch in den Poster-Sessions werden GBN-/GBA-Vertreter*innen Arbeitsergebnisse präsentieren: Am 14. Mai, 16-17 Uhr in der ersten Poster-Session und am 16. Mai (gleiche Zeit) in der zweiten.

 

Questions?

[email protected]

Tel. +49. 30. 450 536 347

Fax +49. 30. 450 753 69 38

© 2025 All rights reserved.

BMBF
top
Biobank Directory European Biobank Directory GBN products Download templates, manuals and other materials